Creation of a Risk-scoring Algorithm for Early Mortality Among Elderly ESRD Patie
创建老年 ESRD 患者早期死亡率的风险评分算法
基本信息
- 批准号:8557705
- 负责人:
- 金额:$ 16.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-07-15 至 2015-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAcute Kidney FailureAffectAlgorithmsAnemiaAwarenessBiologicalBlood VesselsBurn injuryCardiovascular DiseasesCardiovascular systemCaringCessation of lifeChronic Kidney FailureClassificationClinicalClinical Practice GuidelineClinical TrialsCohort StudiesComplexDataData FilesDatabasesDecision MakingDevelopmentDiabetes MellitusDiagnosisDialysis patientsDialysis procedureDigestive System DisordersDisease ManagementDisease OutcomeDistrict of ColumbiaElderlyEmergency SituationEnd stage renal failureEvaluationEventFamilyFamily health statusFoundationsFutureGovernmentGrantGuidelinesHealthHealth ServicesHealthy People 2010IncidenceInformation SystemsInstitutesJointsKidneyKidney DiseasesKidney FailureLaboratoriesLifeLinkLogistic RegressionsMedicalMedicareMedicare claimMethodsModelingMorbidity - disease rateNational Institute of Diabetes and Digestive and Kidney DiseasesNephrologyNutritional statusOutcomeParticipantPatient CarePatientsPhasePopulationPopulation StudyPreparationPreventionPrimary Health CarePrintingProviderPublic HealthRecording of previous eventsRenal Replacement TherapyResearchResearch PersonnelResearch Project GrantsRiskRisk FactorsSamplingSepsisSocietiesSpecialistStagingStratificationSystemTestingUnited StatesUnited States Dept. of Health and Human ServicesUpdateValidationbasedisabilitydisease diagnosisexperiencehigh riskimprovedindexingmortalitynephrogenesisolder patientoutcome forecastpredictive modelingprognosticprogramspsychosocialpublic health relevancetoolurologicuser-friendly
项目摘要
DESCRIPTION (provided by applicant): Creation of a Risk-scoring Algorithm for Early Mortality Among Elderly ESRD Patients Background. The rate of early deaths, those occurring within the three months following the diagnosis of end-stage renal disease (ESRD), are disproportionately high among patients who are 65 and older. Inexorable increases in the incidence of patients with both chronic kidney disease (CKD) and ESRD impel efforts to slow and reverse this urgent public health problem. This study aims to develop a risk-scoring system to aid in the clinical prediction of early death among elderly (>65 years) ESRD patients. Objective. We hypothesize that patients with high rates of "early mortality" soon after dialysis initiation have significant pre-dialysis medical conditions combined with inadequate renal disease management that does not prepare them appropriately for long- term dialysis. Our exploratory research project will identify factors associated with mortality within the first three
months after starting permanent dialysis. We propose to examine the following associated with early mortality: 1) comorbid conditions found within one year prior to dialysis (e.g., cardiovascular events, acute renal failure, sepsis, hypertensive emergencies); 2) medical management prior to dialysis including involvement of a nephrology specialist, management of anemia, nutritional status, and vascular access preparation for dialysis that differentiates the 'emergent versus elective' (i.e., acute onset 'crash and burn' versus planned) transition to ESRD; and 3) use of health services in the latter stages of CKD. Results from these analyses will be used to develop a prognostic model and scoring algorithm for early mortality among dialysis patients. Methods. Using historical Medicare claims data, we propose to conduct a retrospective cohort study to develop a user friendly prognostic index. To identify the study population, we will construct a complete renal failure patient history by linking the pre-dialysis and post dialysis data to assess the predictors of early death. The proposed study is unique in linking the 2000-2009 ESRD data files to the 5% Chronic Kidney Disease (CKD) sample that has recently become available for research purposes. The total number of Medicare-eligible CKD patients from this period is approximately 831,000; of these, roughly 10% become ESRD-eligible and form the basis of our study population. Multivariate logistic regression models will b used to test each hypothesis and identify the significant risk factors for early mortality. Significance. We plan to identify potentially "modifiable" factors that are associated with early death among a population that transitions from CKD to ESRD requiring expensive, permanent and life-altering dialysis therapy. Given the high mortality rates during the first year after dialsis, accurate prediction of those destined for early death would be useful to patients and their families, providers, and society in making decisions about treatment.
描述(由申请人提供):在老年ESRD患者背景中创建一种为早期死亡率的风险评分算法。在65岁及65岁及65岁以上的患者中,诊断出终末期肾脏疾病(ESRD)后三个月内发生的早期死亡率不成比例。慢性肾脏疾病(CKD)和ESRD患者的发病率不可阻碍地增加,并推动了缓慢和扭转这一紧急公共卫生问题的努力。这项研究旨在开发一种风险评分系统,以帮助老年人(> 65岁)ESRD患者对早期死亡的临床预测。客观的。我们假设透析起步后不久,“早期死亡率”率高的患者患有明显的透析前医疗状况,以及肾脏疾病管理不足,无法为长期透析做好适当的准备。我们的探索性研究项目将在前三个中确定与死亡率相关的因素
开始永久透析后的几个月。我们建议检查与早期死亡率相关的以下内容:1)在透析前一年内发现的合并症(例如心血管事件,急性肾衰竭,败血症,高血压紧急情况); 2)透析之前的医疗管理包括肾脏学专家的参与,贫血管理,营养状况和血管通道准备透析的准备,以区分“新兴与选举”(即急性发作和燃烧'vers burn versus versus versus versus versed)过渡到ESRD; 3)在CKD的后期使用健康服务。这些分析的结果将用于开发预后模型和透析患者早期死亡率的评分算法。方法。使用历史医疗保险索赔数据,我们建议进行回顾性队列研究,以开发一个用户友好的预后指数。为了确定研究人群,我们将通过连接透析前和透析后数据来构建完整的肾衰竭患者病史,以评估早期死亡的预测因子。拟议的研究在将2000-2009 ESRD数据文件与最近可用于研究目的的5%慢性肾脏病(CKD)样本联系起来方面是独一无二的。此期间,符合医疗保险资格的CKD患者的总数约为831,000;其中,大约有10%的人符合ESRD资格,并构成了我们研究人群的基础。多元逻辑回归模型将用于检验每个假设并确定早期死亡率的重要风险因素。意义。我们计划确定从CKD到ESRD过渡到需要昂贵,永久且改变生命的透析治疗的人群中与早期死亡有关的潜在“可修改”因素。鉴于拨号后第一年的死亡率很高,因此准确预测原定为早期死亡的人对患者及其家人,提供者和社会在做出有关治疗的决策方面有用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mae Thamer其他文献
Mae Thamer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mae Thamer', 18)}}的其他基金
Do Safety Warnings Change Prescribing among the US Dialysis Population?
安全警告会改变美国透析人群的处方吗?
- 批准号:
8267550 - 财政年份:2011
- 资助金额:
$ 16.93万 - 项目类别:
Do Safety Warnings Change Prescribing among the US Dialysis Population?
安全警告会改变美国透析人群的处方吗?
- 批准号:
8145420 - 财政年份:2011
- 资助金额:
$ 16.93万 - 项目类别:
相似国自然基金
抑制MBD2通过下调Rac1和Pcbp2保护脓毒症AKI的机制研究
- 批准号:81870475
- 批准年份:2018
- 资助金额:57.0 万元
- 项目类别:面上项目
Gasdermin家族蛋白介导的细胞程序性坏死在急性肾衰竭中的作用
- 批准号:81700596
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
基于腺苷相关蛋白同步化表达探讨缺血预适应保护急性肾功能衰竭的分子机制
- 批准号:81200540
- 批准年份:2012
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
生物人工肾小管治疗ARF/MODS的免疫调节作用
- 批准号:30570862
- 批准年份:2005
- 资助金额:30.0 万元
- 项目类别:面上项目
相似海外基金
Integrated, Individualized, and Intelligent Prescribing (I3P) Clinical Trial Network
一体化、个体化、智能处方(I3P)临床试验网络
- 批准号:
10822651 - 财政年份:2023
- 资助金额:
$ 16.93万 - 项目类别:
Shifting paradigms to emerging toxins in freshwater cyanobacterial blooms
淡水蓝藻水华中新出现的毒素的范式转变
- 批准号:
10912318 - 财政年份:2023
- 资助金额:
$ 16.93万 - 项目类别:
Novel Combinations of Natural Product Compounds for Treatment of Alzheimer Disease and Related Dementias
用于治疗阿尔茨海默病和相关痴呆症的天然产物化合物的新组合
- 批准号:
10603708 - 财政年份:2023
- 资助金额:
$ 16.93万 - 项目类别:
Resident Memory T cells in Chronic Kidney Disease
慢性肾脏病中的常驻记忆 T 细胞
- 批准号:
10676628 - 财政年份:2023
- 资助金额:
$ 16.93万 - 项目类别:
MLL1 drives collaborative leukocyte-endothelial cell signaling and thrombosis after coronavirus infection
MLL1在冠状病毒感染后驱动白细胞-内皮细胞信号传导和血栓形成
- 批准号:
10748433 - 财政年份:2023
- 资助金额:
$ 16.93万 - 项目类别: